Table 2. Glycemic measures at the time of biomarker collection.
| Variable | Entire Cohort | Euglycemia | Hyperglycemia | p value | Hypoglycemia | Both Hyperglycemia and Hypoglycemia |
|---|---|---|---|---|---|---|
| Plasma Glucose (mg/dL) | 118 (88–153) | 96 (81–124) | 146 (117–218) | 0.002 | 77 (56–82) | 124 (73–133) |
| Plasma Insulin (μIU/mL) | 9.8 (5.4–19.7) | 8.1 (5.3–13.6) | 12.9 (6.8–29.6) | 0.005 | 7.8 (5.6–17.6) | 5.4 (2.2–10.7) |
| Plasma C-Peptide (pg/mL) | 2375 (1270–4442) | 2151 (1349–3767) | 2880 (1586–6916) | 0.070 | 1969 (1723–3912) | 428 (241–928) |
| HOMA-IR | 2.7 (1.4–6.5) | 1.8 (1.1–3.6) | 5.7 (2.2–12.4) | 0.002 | 1.5 (1.1–2.4) | 1.9 (0.4–3.4) |
Data are presented as median (interquartile range). p-values are for differences between euglycemia and hyperglycemia groups by rank sum test and are adjusted for multiple comparisons. Abbreviations: IU- international units; HOMA- homeostatic model-assessment of insulin resistance.